Soros Fund Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-300,000
Closed -$34.1M 223
2024
Q3
$34.1M Hold
300,000
0.49% 49
2024
Q2
$37.1M Buy
300,000
+125,000
+71% +$16.1M 0.67% 45
2024
Q1
$23.1M Sell
175,000
-50,000
-22% -$6.16M 0.38% 72
2023
Q4
$24.5M Buy
+225,000
New +$23.4M 0.32% 79
2017
Q4
Sell
-3,668
Closed -$224K 249
2017
Q3
$224K Buy
+3,668
New +$222K 0.01% 220
2014
Q3
Sell
-90,966
Closed -$5.02M 320
2014
Q2
$5.02M Buy
+90,966
New +$4.96M 0.04% 212
2014
Q1
Sell
-157,200
Closed -$7.51M 341
2013
Q4
$7.51M Buy
+157,200
New +$7.19M 0.06% 163
2013
Q3
Sell
-262,000
Closed -$11.6M 255
2013
Q2
$11.6M Buy
+262,000
New +$11.7M 0.13% 108

Other funds holding MRK

Soros Fund Management's MRK Position: Q4 2024 in Review

Soros Fund Management sold out of Merck (MRK) in Q4 2024, closing a stake of 300,000 shares — an estimated $34.1M sold.

Soros Fund Management first reported a position in MRK in Q2 2013 and held it in 8 quarters. The position peaked at $37.1M in Q2 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Soros Fund Management reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Soros Fund Management sold 300,000 Merck shares in Q4 2024, an estimated $34.1M.
  • Soros Fund Management first reported a position in Merck in Q2 2013 and held it in 8 quarters.
  • Soros Fund Management's Merck position peaked at $37.1M in Q2 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Soros Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.